M&T Bank’s Editas Medicine EDIT Stock Holding History

M&T Bank’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,221	Closed	-$296K	–	1595
2020 Q4	$296K	Sell	4,221 -7,022	-62%	-$288K	﹤0.01%	1343
2020 Q3	$315K	Buy	11,243 +19	+0.2%	+$619	﹤0.01%	1211
2020 Q2	$332K	Sell	11,224 -1,099	-9%	-$28.7K	﹤0.01%	1139
2020 Q1	$244K	Buy	12,323 +489	+4%	+$12.3K	﹤0.01%	1243
2019 Q4	$350K	Sell	11,834 -21	-0.2%	-$524	﹤0.01%	1004
2019 Q3	$270K	Buy	11,855 +291	+3%	+$7.21K	﹤0.01%	1258
2019 Q2	$286K	Sell	11,564 -1,761	-13%	-$42K	﹤0.01%	1251
2019 Q1	$326K	Buy	+13,325	New	+$302K	﹤0.01%	1165
2018 Q4	–	Sell	-7,056	Closed	-$225K	–	1462
2018 Q3	$225K	Hold	7,056	–	–	﹤0.01%	1378
2018 Q2	$253K	Hold	7,056	–	–	﹤0.01%	1304
2018 Q1	$234K	Sell	7,056 -1,857	-21%	-$66.2K	﹤0.01%	1352
2017 Q4	$274K	Hold	8,913	–	–	﹤0.01%	1281
2017 Q3	$214K	Buy	+8,913	New	+$170K	﹤0.01%	1386

Other funds holding EDIT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

M&T Bank's EDIT Position: Q1 2021 in Review

M&T Bank sold out of Editas Medicine (EDIT) in Q1 2021, closing a stake of 4,221 shares — an estimated $296K sold.

M&T Bank first reported a position in EDIT in Q3 2017 and held it in 13 quarters. The position peaked at $350K in Q4 2019. 312 funds tracked by Wall St. Rank hold EDIT as of Q1 2021.

M&T Bank reported no remaining Editas Medicine position as of Q1 2021 after selling out during the quarter.
M&T Bank sold 4,221 Editas Medicine shares in Q1 2021, an estimated $296K.
M&T Bank first reported a position in Editas Medicine in Q3 2017 and held it in 13 quarters.
M&T Bank's Editas Medicine position peaked at $350K in Q4 2019.
312 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2021.

Based on M&T Bank's 13F filing for Q1 2021, filed 6 May 2021.